EX-15.1 7 f20f2022ex15-1_canfitebio.htm CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

| 1. | Registration Statement (Form F-3 No. 333-236064) of Can-Fite Biopharma Ltd.,

| 2. | Registration Statement (Form F-3 No. 333-249063) of Can-Fite Biopharma Ltd.,

| 3. | Registration Statement (Form F-3 No. 333-262055) of Can-Fite Biopharma Ltd., and

| 4. | Registration Statement (Form S-8 No. 333-227753) pertaining to the 2003 Israeli Share Option Plan and 2013 Global Incentive Option Scheme of Can-Fite Biopharma Ltd.

of our report dated March 30, 2023, with respect to the consolidated financial statements of Can-Fite Biopharma Ltd. included in this Annual Report (Form 20-F) of Can-Fite Biopharma Ltd. for the year ended December 31, 2022.

Tel-Aviv, Israel |  | /s/ Kost Forer Gabbay & Kasierer
March 30, 2023 |  | A Member of Ernst & Young Global